For healthcare professionals. Compounded preparations are dispensed on a doctor’s prescription.

Short answer: Compounded kacip fatimah capsules are prepared for one named patient on a doctor’s prescription under Good Compounding Practice. Trial evidence is limited. A 2014 randomised trial of a Labisia pumila water extract reported improved vasomotor symptoms (PMID 25000151), while a 2020 trial of a two-herb combination found no significant between-group difference in hot flushes (PMID 33061884).

Fresh kacip fatimah leaves and stems on a prescriber's consulting desk

Why a prescriber must specify the preparation

Kacip fatimah (Labisia pumila) is studied in menopausal women, and a prescriber who considers it has to decide what is being prescribed rather than choose a product from a shelf. The two human trials discussed here used different preparations: a Labisia pumila water extract in one study, and a combination of Labisia pumila with Eurycoma longifolia in the other. Neither trial tested the capsule specified in this guide, so each result applies only to the preparation that was studied.

What the randomised trials report

Labisia pumila water extract, 2014

A randomised, double-blind, placebo-controlled study in healthy pre- and postmenopausal women aged 40 to 60 years, conducted in Kelantan, Malaysia, compared a Labisia pumila var alata water extract with placebo (Journal of Medicinal Food, 2014; PMID 25000151). The abstract reports that subjects in the herbal group showed improved vasomotor symptoms, alongside memory and concentration, menstrual symptoms and sleep problems. In postmenopausal women supplemented with the extract, the abstract reports no changes in luteinising hormone, follicle-stimulating hormone or 17β-Estradiol.

Labisia pumila and Eurycoma longifolia combination, 2020

A randomised, double-blind, placebo-controlled, 24-week study enrolled 119 women aged 41 to 55 years who were experiencing peri-menopausal or menopausal symptoms (Food & nutrition research, 2020; PMID 33061884). It tested a combined Labisia pumila and Eurycoma longifolia product against placebo. The abstract reports significant improvements in hot flush symptoms in both the combination and placebo groups, with no significant difference between groups.

Limits of the evidence

The two trials are small, use different preparations and measure different endpoints. The 2014 trial used a Women’s Health Questionnaire to assess quality of life, and the 2020 trial’s primary endpoint was the change in frequency and severity of hot flushes. Neither is a trial of a single capsule of the kind described in this guide, and neither result should be read as a predictable effect in an individual patient.

What the prescription must specify

The prescription names the patient, the active (kacip fatimah, Labisia pumila extract), the form, the strength per capsule, the quantity, the directions and the prescriber’s details. The strength, quantity and directions are the prescriber’s decision for the named patient. The trials cited here do not set a strength for a compounded capsule.

Forms Lynnity prepares

For this preparation the form is a capsule. Lynnity prepares capsules and oral liquids on a doctor’s prescription, and the prescriber chooses the form for the named patient. The capsule form lets the prescriber state the strength and quantity on the prescription. An oral liquid is the other form a prescriber may specify.

Safety and interactions

The 2014 abstract reports that the safety profiles were normal in that study. Safety, contraindications and interactions for a named patient remain the prescribing doctor’s assessment.

Related reading

For the wider menopause picture, see Lynnity’s menopause treatment page for Malaysia. Related prescriber guides include royal jelly for postmenopausal symptoms, compounded topical estriol for menopause and BHRT and menopause-related bone, liver and lipid changes. Compounding is carried out under Good Compounding Practice at Lynnity’s compounding laboratory.

How to prescribe

Only a registered Malaysian doctor can issue the prescription. It must state the active (kacip fatimah, Labisia pumila extract), the form (capsule), the strength per capsule, the quantity, the directions and the named patient’s details. Send the prescription and any questions through the Lynnity contact page. Contact Vitthia Rama Murti, RPh (RPh 15632), through that page.

Reviewed by Vitthia Rama Murti, RPh (RPh 15632).

Frequently asked questions

Can a doctor prescribe compounded kacip fatimah capsules in Malaysia?

Yes. A compounded kacip fatimah capsule can be prepared for one named patient on a registered Malaysian doctor’s prescription, under Good Compounding Practice. The prescription specifies the active, the form, the strength, the quantity and the directions. The prescribing doctor remains responsible for assessing the patient.

What did the trials of Labisia pumila report in menopausal women?

A 2014 randomised, placebo-controlled trial of a Labisia pumila water extract in healthy pre- and postmenopausal women reported improved vasomotor symptoms in the herbal group (PMID 25000151). A 2020 randomised, placebo-controlled trial of a Labisia pumila and Eurycoma longifolia combination reported significant improvement in hot flushes in both groups, with no significant difference between groups (PMID 33061884).

Does the evidence show that kacip fatimah is effective for menopausal symptoms?

The evidence is limited and mixed. One trial reported improvement in vasomotor symptoms with a water extract, while a combination-product trial found no significant difference between groups for hot flushes. Neither studied the capsule described in this guide, and neither establishes a consistent benefit. A prescribing doctor should weigh these results against the individual patient before prescribing.

WhatsApp us